Skip to search.
 FTSE 100 Down 0.93%

AbbVie Inc. (ABBV)

-NYSE
62.29 Down 0.30(0.48%) 17 Apr 21:01
|After Hours: : 63.00 Up 0.71 (1.14%) 18 Apr 00:55
Add to Portfolio
Prev Close:62.59
Open:62.12
Bid:62.65 x 100
Ask:63.00 x 100
1y Target Est:69.75
Beta:1.66
Next Earnings Date:23-Apr-15ABBV Earnings announcement
Day's Range:61.87 - 62.79
52wk Range:48.40 - 70.76
Volume:9,905,645
Avg Vol (3m):12,487,700
Market Cap:99.28b
P/E (ttm):56.63
EPS (ttm):1.10
Div & Yield:2.04 (3.50%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVDown 0.48%99.28b
MRKDown 1.66%161.44b
NVSDown 0.82%245.76b
PFEDown 0.43%214.76b

Key Statistics

Forward P/E (1 yr):12.36
P/S (ttm):5.00
Ex-Dividend Date:13-Apr-15

Analysts

Annual EPS Est (Dec-15) :4.19
Quarterly EPS Est (Mar-15) :0.85
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):0.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback